IMMUNODEFICIENCY
Clinical trials for IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell addback aims to slash infection risk in child stem cell recipients
Disease control Recruiting nowThis study tests whether adding a specific type of immune cell (memory T cells) after a stem cell transplant can help prevent serious viral and fungal infections. About 100 children and young adults with blood cancers, immune disorders, or bone marrow failure will receive this ex…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 07:38 UTC
-
Could a stem cell transplant tame VEXAS? new trial aims to find out
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can control VEXAS syndrome, a rare and serious autoinflammatory disease. About 54 adults aged 18 to 75 who have not responded to standard treatments will receive donor stem cells after chemotherapy. The goal is …
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New hope for vulnerable patients: can stronger antivirals beat COVID-19?
Disease control Recruiting nowThis study looks at whether giving a combination of two antiviral drugs (remdesivir plus nirmatrelvir/r) or a longer treatment course (10 days instead of 5) can help immunocompromised people clear COVID-19 faster. About 256 adults with mild to moderate COVID-19 and weakened immun…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: Calmy Alexandra • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Stem cell transplant offers hope for rare immune disorder
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can treat GATA2 deficiency, a genetic condition that weakens the immune system and raises the risk of leukemia. Participants aged 6 to 70 receive chemotherapy or radiation before the transplant to prepare their …
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for vulnerable patients: can stronger antiviral cocktails beat COVID-19?
Disease control Recruiting nowThis study looks at whether giving a combination of two antiviral drugs (remdesivir plus nirmatrelvir/r) works better than the standard single drug for COVID-19 in people with weakened immune systems. It also tests if taking the medication for 10 days instead of 5 helps clear the…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Parkinson's drug may weaken immunity – new study investigates
Knowledge-focused Recruiting nowThis study looks at whether clozapine, a drug used to treat psychosis in Parkinson's disease, causes immune system problems. Researchers will measure changes in infection-fighting blood cells and antibodies in 24 patients over 6 months to a year. The goal is to understand the ris…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Scientists hunt for genes behind immune system failures
Knowledge-focused Recruiting nowThis study looks for genes that cause immune disorders like severe infections, allergies, or autoimmune diseases. Researchers will collect blood, cheek swabs, or skin samples from 5,000 patients and their family members. The goal is to understand these conditions better and help …
Matched conditions: IMMUNODEFICIENCY
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC